A comprehensive approach toward concomitant triclabendazole polymorphism in pharmaceutical products | ||
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Química Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Química Rosario | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Química Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Química Rosario | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Química Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Química Rosario | |
| dc.contributor.author | Salazar Rojas, Duvernis Maria | |
| dc.contributor.author | Kaufman, Teodoro Saul | |
| dc.contributor.author | Maggio, Ruben Mariano | |
| dc.date.issued | 2021-04 | |
| dc.description.abstract | Triclabendazole (TCB) is a highly effective and low-cost anti-parasitic active pharmaceutical ingredient (API) used in the treatment of fascioliasis, a neglected tropical disease caused by Fasciola hepatica. It belongs to Class II/IV in the Biopharmaceutics Classification System, where API dissolution results in the limiting step for its absorption. TCB exhibits tautomeric and conformational polymorphism, where Form I contains different conformations of tautomer A, and Form II is a 1:1 conglomerate of tautomers A and B, each in a single conformation. Since both forms may precipitate concomitantly during the preparation of the API, the control of polymorphic quality is critical for this anti-parasitic agent. A comprehensive approach was developed to address the determination of the polymorphic quality of drug-products when pure solid forms are not available, such as the case of concomitant crystallization of TCB I and II. First, both solid forms of the drug were isolated and characterized (digital optical microscopy, differential scanning calorimetry, hot stage microscopy, mid-infrared, near-infrared and solid-state 13C nuclear magnetic resonance). Next, lab-scale crystallization of Forms I and II was optimized, following a smart approach (green solvent and robust procedures), in order to obtain standards for calibration. A strategy based on NIR spectroscopy coupled to PLS was developed and validated to assess the polymorphic composition of drug-products. The new method was successfully applied to formulated products. The intrinsic dissolution rate of the pure forms demonstrated that Form II dissolves up to 60% faster than Form I, reinforcing the need for polymorphic control to assure the lot-to-lot equivalence. Thus, NIR-PLS emerges as a unique tool able to control the risk of polymorphic changes and their impact on bioavailability in formulated products. | es |
| dc.description.fil | Fil: Salazar Rojas, Duvernis Maria. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Química Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Química Rosario; Argentina | |
| dc.description.fil | Fil: Kaufman, Teodoro Saul. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Química Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Química Rosario; Argentina | |
| dc.description.fil | Fil: Maggio, Ruben Mariano. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Química Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Química Rosario; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Salazar Rojas, Duvernis Maria; Kaufman, Teodoro Saul; Maggio, Ruben Mariano; A comprehensive approach toward concomitant triclabendazole polymorphism in pharmaceutical products; Elsevier; Journal of Drug Delivery Science and Technology; 62; 4-2021; 1-10 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1773-2247 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/148652 | |
| dc.journal.ciudad | Amsterdam | es |
| dc.journal.pagination | 1-10 | es |
| dc.journal.pais | Países Bajos | es |
| dc.journal.title | Journal of Drug Delivery Science and Technology | es |
| dc.journal.volume | 62 | es |
| dc.language.iso | eng | es |
| dc.publisher | Elsevier | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S1773224721000666 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.jddst.2021.102386 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | CONCOMITANT POLYMORPHISM | es |
| dc.subject | CONCOMITANT POLYMORPHS | es |
| dc.subject | DISSOLUTION | es |
| dc.subject | DSC AND SSNMR | es |
| dc.subject | NIR-PLS | es |
| dc.subject | SOLID-STATE CHARACTERIZATION | es |
| dc.subject | TRICLABENDAZOLE | es |
| dc.subject | VIBRATIONAL SPECTROSCOPY | es |
| dc.subject.classification | Química Analítica | es |
| dc.subject.classification | Ciencias Químicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | A comprehensive approach toward concomitant triclabendazole polymorphism in pharmaceutical products | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.92b5e94e-15fd-4f34-92b2-aea9942f57aa_A.pdf
- Tamaño:
- 3.21 MB
- Formato:
- Adobe Portable Document Format